Insider · CIK 0001499254
Lewis H Titterton jr
Files at ANIX (Anixa Biosciences Inc), PRKR (PARKERVISION INC). First filing Jan 17, 2025, latest Sep 25, 2026.
In brief
Lewis H Titterton jr files SEC Form 4 as director at ANIX (Anixa Biosciences Inc), and also at PRKR (PARKERVISION INC). Since Jan 17, 2025, Lewis H Titterton jr has reported 12 open-market buys worth $1.3M and 0 open-market sells worth $0, the latest filed on Sep 25, 2026.
After Lewis H Titterton jr's past buys, the stock beat the S&P 500 by a median 8.2% over six months (n = 7), and 57% of those buys were ahead of the index at six months. InsiderTell labels that a positive record.
The newest scored trade: bought $132k of ANIX on Sep 23, 2026, filed Sep 25, 2026, scored 46 (moderate). In the last 12 months: 6 buys worth $1.2M and 0 sells worth $0.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ANIX: Anixa Biosciences Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
PRKR: PARKERVISION INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Anixa Biosciences Inc | $132k 49,036 shares | +5% | - | |
| 35Weak | Anixa Biosciences Inc | $27k 10,000 shares | +1% | - | |
| 47Moderate | Anixa Biosciences Inc | $42k 12,000 shares | +1% | +47% from low-34% from high | |
| 36Weak | Anixa Biosciences Inc | $9,174 2,797 shares | +0% | +49% from low-33% from high | |
| 26Weak | Anixa Biosciences Inc | $7,487 2,836 shares | +0% | +11% from low-50% from high | |
| 50Moderate | PRKRbuy PARKERVISION INC | $1.0M 4,761,905 shares | +125% | - | |
| 44Moderate | Anixa Biosciences Inc | $31k 10,000 shares | +1% | +44% from low-23% from high | |
| 39Weak | Anixa Biosciences Inc | $31k 10,000 shares | +1% | +47% from low-21% from high | |
| 30Weak | Anixa Biosciences Inc | $8,820 3,000 shares | +0% | - | |
| 30Weak | Anixa Biosciences Inc | $6,020 2,000 shares | +0% | - | |
| 30Weak | Anixa Biosciences Inc | $16k 6,000 shares | +1% | - | |
| 35Weak | Anixa Biosciences Inc | $26k 10,000 shares | +1% | - |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +49,036 | $2.69 | $132k | 1,046,003 | 18 d ago |
| Sep 10, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +10,000 | $2.73 | $27k | 996,967 | 29 d ago |
| Jul 20, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +12,000 | $3.47 | $42k | 986,967 | Jul 20, 2026 |
| Jul 15, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +2,797 | $3.28 | $9,174 | 974,967 | Jul 16, 2026 |
| Jun 16, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +2,836 | $2.64 | $7,487 | 972,170 | Jun 17, 2026 |
| Jan 22, 2026 | PRKR PARKERVISION INC | AGrant or award Option to Purchase Common Stockderivative | +370,000 | $0.24 | $89k | 370,000 | Jan 26, 2026 |
| Jan 5, 2026 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 6, 2026 |
| Dec 15, 2025 | ANIX Anixa Biosciences Inc | MOption exercise Common Stock | +16,000 | $2.92 | $47k | 969,334 | Dec 16, 2025 |
| Dec 15, 2025 | ANIX Anixa Biosciences Inc | MOption exercise Employee Stock Optionderivative | -16,000 | $0.00 | $0 | 0 | Dec 16, 2025 |
| Nov 18, 2025 | PRKR PARKERVISION INC | POpen-market purchase Common Stock | +4,761,905 | $0.21 | $1.0M | 8,578,170 | Nov 18, 2025 |
| Oct 7, 2025 | PRKR PARKERVISION INC | MOption exercise Common Stock | +525,000 | $0.18 | $95k | 3,541,265 | Oct 7, 2025 |
| Oct 7, 2025 | PRKR PARKERVISION INC | MOption exercise Common Stock | +275,000 | $0.20 | $55k | 3,816,265 | Oct 7, 2025 |
| Oct 7, 2025 | PRKR PARKERVISION INC | MOption exercise Nonqualified Stock Optionderivative | -525,000 | $0.18 | $95k | 75,000 | Oct 7, 2025 |
| Oct 7, 2025 | PRKR PARKERVISION INC | MOption exercise Nonqualified Stock Optionderivative | -275,000 | $0.20 | $55k | 0 | Oct 7, 2025 |
| Jul 31, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +10,000 | $3.08 | $31k | 953,334 | Aug 4, 2025 |
| Jul 11, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +10,000 | $3.14 | $31k | 943,334 | Jul 15, 2025 |
| Jul 3, 2025 | PRKR PARKERVISION INC | AGrant or award Common stock | +275,000 | - | - | 3,153,765 | Jul 8, 2025 |
| May 6, 2025 | PRKR PARKERVISION INC | CConversion Common Stock | +1,699,844 | $0.13 | $221k | 2,878,765 | May 9, 2025 |
| May 6, 2025 | PRKR PARKERVISION INC | CConversion Convertible Notederivative | -1,699,844 | $0.13 | $221k | 0 | May 9, 2025 |
| Jan 23, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +2,000 | $2.91 | $5,820 | 932,334 | Jan 27, 2025 |
| Jan 24, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +1,000 | $3.00 | $3,000 | 933,334 | Jan 27, 2025 |
| Jan 22, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +2,000 | $3.01 | $6,020 | 930,334 | Jan 23, 2025 |
| Jan 21, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +6,000 | $2.59 | $16k | 928,334 | Jan 22, 2025 |
| Jan 17, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +10,000 | $2.57 | $26k | 922,334 | Jan 17, 2025 |
| Jan 2, 2025 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 3, 2025 |
| Oct 22, 2024 | ANIX Anixa Biosciences Inc | MOption exercise Common Stock | +16,000 | $2.58 | $41k | 912,334 | Oct 23, 2024 |
| Oct 22, 2024 | ANIX Anixa Biosciences Inc | MOption exercise Employee Stock Optionderivative | -16,000 | $0.00 | $0 | 0 | Oct 23, 2024 |
Questions about Lewis H Titterton jr
Answered from the filings on this page, as of the latest one.
Is Lewis H Titterton jr buying or selling?
In the last 12 months Lewis H Titterton jr reported 6 open-market buys worth $1.2M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $132k of ANIX on Sep 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Lewis H Titterton jr's past buys perform?
Measured from the first close after each filing, the stock beat the S&P 500 by a median 8.2% over six months across 7 past buys, with 57% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Lewis H Titterton jr file Form 4?
Lewis H Titterton jr has filed Form 4 at ANIX (Anixa Biosciences Inc); PRKR (PARKERVISION INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.